News

FDA expands approval of first gene therapy for rare form of muscular dystrophy

todayJune 20, 2024 6

Background
share close
The US Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation.

​ The US Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation. Read More Breaking News, Latest News and Videos | CNN 

Written by:

Rate it